Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer

BACKGROUND: Paxillin (PXN) has been found to be aberrantly regulated in various malignancies and involved in tumor growth and invasion. The clinicopathological and prognostic significance of PXN in gastric cancer is still unclear. METHODS: The expression of PXN was determined in paired gastric cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Dong-liang, Wang, Zhi-qiang, Ren, Chao, Zeng, Zhao-lei, Wang, De-shen, Luo, Hui-yan, Wang, Feng, Qiu, Miao-zhen, Bai, Long, Zhang, Dong-sheng, Wang, Feng-hua, Li, Yu-hong, Xu, Rui-hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228400/
https://www.ncbi.nlm.nih.gov/pubmed/24180516
http://dx.doi.org/10.1186/1479-5876-11-277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228400/
https://www.ncbi.nlm.nih.gov/pubmed/24180516
http://dx.doi.org/10.1186/1479-5876-11-277

Ejemplares similares